{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:47:48Z","timestamp":1784242068574,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/18808-5"],"award-info":[{"award-number":["2017\/18808-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/02648-4"],"award-info":[{"award-number":["2019\/02648-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/26444-9"],"award-info":[{"award-number":["2019\/26444-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/01906-0"],"award-info":[{"award-number":["2021\/01906-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/01863-9"],"award-info":[{"award-number":["2021\/01863-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.neurol.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T01:30:53Z","timestamp":1689471053000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["ADAM10 as a biomarker for Alzheimer's disease: A systematic review"],"prefix":"10.1016","volume":"180","author":[{"given":"M.P.","family":"Oliveira Monteiro e Pereira de Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-2566","authenticated-orcid":false,"given":"R.","family":"Valle Pedroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mantellatto Grigoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vicente Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R.","family":"Manzine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6385-7392","authenticated-orcid":false,"given":"M.R.","family":"Cominetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neurol.2023.04.002_bib0235","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2174\/1381612826666200114105515","article-title":"Blood-based biomarkers of Alzheimer's disease: the long and winding road","volume":"26","author":"Manzine","year":"2020","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10.1016\/j.neurol.2023.04.002_bib0240","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.neurol.2023.04.002_bib0245","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1074\/jbc.275.4.2568","article-title":"Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network","volume":"275","author":"Skovronsky","year":"2000","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.neurol.2023.04.002_bib0250","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1046\/j.1471-4159.2000.0752133.x","article-title":"Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain","volume":"75","author":"Marcinkiewicz","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurol.2023.04.002_bib0255","first-page":"2","article-title":"Alpha- and beta-secretase activity in platelets of Alzheimer disease patients","volume":"15","author":"Colciaghi","year":"2001","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.neurol.2023.04.002_bib0260","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/01.WNL.0000106953.49802.9C","article-title":"Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease","volume":"62","author":"Colciaghi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2023.04.002_bib0265","first-page":"21","article-title":"Alpha and beta secretase activity in platelets of Alzheimer's disease patients","volume":"77","author":"Colciaghi","year":"2001","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neurol.2023.04.002_bib0270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/gps.4020","article-title":"Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease","volume":"29","author":"Manzine","year":"2013","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.neurol.2023.04.002_bib0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130125","article-title":"Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease","volume":"36","author":"Manzine","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2023.04.002_bib0280","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000345983","article-title":"ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly","volume":"35","author":"Manzine","year":"2013","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10.1016\/j.neurol.2023.04.002_bib0285","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-150737","article-title":"Increase of alpha-secretase ADAM10 in platelets along cognitively healthy aging","volume":"50","author":"Schuck","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2023.04.002_bib0290","article-title":"ADAM10 plasma and CSF levels are increased in mild Alzheimer's disease","author":"Vatanabe","year":"20212252416","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2023.04.002_bib0295","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/acssensors.9b02463","article-title":"Early diagnosis of Alzheimer's disease in blood using a disposable electrochemical microfluidic platform","volume":"5","author":"de Oliveira","year":"2020","journal-title":"ACS Sensors"},{"key":"10.1016\/j.neurol.2023.04.002_bib0300","article-title":"Blood-based ATN biomarkers of Alzheimer's disease: a meta-analysis","author":"Koychev","year":"2020791177","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13041-019-0448-1","article-title":"Blood-based molecular biomarkers for Alzheimer's disease","volume":"12","author":"Zetterberg","year":"2019","journal-title":"Mol Brain"},{"issue":"3","key":"10.1016\/j.neurol.2023.04.002_bib0310","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-170773","article-title":"The past and the future of Alzheimer's disease fluid biomarkers","volume":"62","author":"Blennow","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2023.04.002_bib0315","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.neurol.2023.04.002_bib0320","series-title":"Quality assessment tool for observational cohort and cross-sectional studies","author":"NHLBIN","year":"2014"},{"issue":"3","key":"10.1016\/j.neurol.2023.04.002_bib0325","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/1354750X.2015.1062554","article-title":"ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects","volume":"20","author":"Manzine","year":"2015","journal-title":"Biomarkers"},{"issue":"4","key":"10.1016\/j.neurol.2023.04.002_bib0330","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3233\/JAD-160813","article-title":"Protein expression of BACE1 is downregulated by donepezil in Alzheimer's disease platelets","volume":"55","author":"Sarno","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/j.neurol.2023.04.002_bib0335","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00406-018-0905-3","article-title":"Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients","volume":"269","author":"de Fran\u00e7a Bram","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1255-9","article-title":"Levels of ADAM10 are reduced in Alzheimer's disease CSF","volume":"15","author":"Sogorb-Esteve","year":"2018","journal-title":"J Neuroinflamm"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00708-0","article-title":"\u03b1-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer's disease","volume":"12","author":"Ag\u00fcero","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.neurol.2023.04.002_bib0350","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03402076","article-title":"\u03b1-Secretase ADAM10 as well as \u03b1 APPs is reduced in platelets and CSF of Alzheimer disease patients","volume":"8","author":"Colciaghi","year":"2002","journal-title":"Mol Med"},{"issue":"7","key":"10.1016\/j.neurol.2023.04.002_bib0355","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11064-013-1039-7","article-title":"Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI)","volume":"38","author":"Bermejo-Besc\u00f3s","year":"2013","journal-title":"Neurochem Res"},{"issue":"5","key":"10.1016\/j.neurol.2023.04.002_bib0360","doi-asserted-by":"crossref","first-page":"e13358","DOI":"10.1111\/acel.13358","article-title":"Platelet biomarkers for a descending cognitive function: a proteomic approach","volume":"20","author":"Yu","year":"2021","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0365","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1567205015666181109103742","article-title":"Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood","volume":"16","author":"Wongchitrat","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.neurol.2023.04.002_bib0370","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biopha.2018.05.028","article-title":"Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and A\u03b2 expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: a pilot study","volume":"104","author":"Vinothkumar","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2023.04.002_bib0375","first-page":"53","article-title":"Platelet amyloid precursor protein processing: a biomarker for Alzheimer's disease","volume":"240","author":"Tang","year":"2006","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.neurol.2023.04.002_bib0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-130125","article-title":"Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease","volume":"36","author":"Manzine","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2023.04.002_bib0385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease","volume":"22","author":"Ding","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2023.04.002_bib0390","article-title":"microRNA 221 targets ADAM10 mRNA and is downregulated in Alzheimer's disease","author":"Manzine","year":"2017611113","journal-title":"J Alzheimers Dis"},{"issue":"16","key":"10.1016\/j.neurol.2023.04.002_bib0395","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0047-6374(01)00315-3","article-title":"Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target","volume":"122","author":"Padovani","year":"2001","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-5960-2-65","article-title":"Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?","volume":"2","author":"Veitinger","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"16","key":"10.1016\/j.neurol.2023.04.002_bib0405","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1097\/00001756-200211150-00008","article-title":"Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus","volume":"13","author":"Gatta","year":"2002","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0410","first-page":"1","article-title":"ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study","volume":"13","author":"Monteiro","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"7","key":"10.1016\/j.neurol.2023.04.002_bib0415","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.cell.2017.11.014","article-title":"Structural basis for regulated proteolysis by the alpha-secretase ADAM10","volume":"171","author":"Seegar","year":"2017","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.neurol.2023.04.002_bib0420","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.1074\/jbc.M805894200","article-title":"ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase","volume":"284","author":"Tousseyn","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurol.2023.04.002_bib0425","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00018-019-03184-4","article-title":"Degradome of soluble ADAM10 and ADAM17 metalloproteases","volume":"77","author":"Scharfenberg","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.neurol.2023.04.002_bib0430","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0014-5793(00)01528-3","article-title":"The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3","volume":"473","author":"Amour","year":"2000","journal-title":"FEBS Lett"},{"issue":"47","key":"10.1016\/j.neurol.2023.04.002_bib0435","doi-asserted-by":"crossref","first-page":"39753","DOI":"10.1074\/jbc.M112.416503","article-title":"The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression","volume":"287","author":"Haining","year":"2012","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.neurol.2023.04.002_bib0440","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s00018-012-0960-2","article-title":"Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10","volume":"69","author":"Prox","year":"2012","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.neurol.2023.04.002_bib0445","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00018-015-2111-z","article-title":"TspanC8 tetraspanins differentially regulate the cleavage of ADAM10 substrates, Notch activation and ADAM10 membrane compartmentalization","volume":"73","author":"Jouannet","year":"2016","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.neurol.2023.04.002_bib0450","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4049\/jimmunol.1402643","article-title":"Genotoxic stress induces senescence-associated ADAM10-dependent release of NKG2D MIC ligands in multiple myeloma cells","volume":"195","author":"Zingoni","year":"2015","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.neurol.2023.04.002_bib0455","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-020-00755-7","article-title":"Associations of Alzheimer's disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration","volume":"13","author":"Tan","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.1016\/j.neurol.2023.04.002_bib0460","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723009694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378723009694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:47:51Z","timestamp":1758520071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378723009694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0035378723009694"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2023.04.002","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAM10 as a biomarker for Alzheimer's disease: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}